Title:
ANHYDROUS DASATINIB-CONTAINING PREPARATION
Document Type and Number:
WIPO Patent Application WO/2019/103033
Kind Code:
A1
Abstract:
Provided is an anhydrous dasatinib-containing preparation which is characterized by containing anhydrous dasatinib, titanium oxide or a coloring agent or an antioxidant. In one embodiment, the anhydrous dasatinib-containing preparation has improved photostability during storage. When the content of the anhydrous dasatinib is taken as 1, the weight ratio of the titanium oxide may be more than 0 and not more than 2. When the content of the anhydrous dasatinib is taken as 1, the weight ratio of the coloring agent may be more than 0 and not more than 1. When the content of the anhydrous dasatinib is taken as 1, the weight ratio of the antioxidant may be more than 0 and not more than 0.5.
Inventors:
OIKAWA MICHINORI (JP)
YAMAMOTO HIROYUKI (JP)
KIKUOKA HIROAKI (JP)
YAMAMOTO HIROYUKI (JP)
KIKUOKA HIROAKI (JP)
Application Number:
PCT/JP2018/042968
Publication Date:
May 31, 2019
Filing Date:
November 21, 2018
Export Citation:
Assignee:
SAWAI SEIYAKU KK (JP)
International Classes:
A61K31/506; A61K9/20; A61K9/28; A61K47/02; A61K47/10; A61K47/22; A61P35/02
Domestic Patent References:
WO2017103057A1 | 2017-06-22 | |||
WO2013054872A1 | 2013-04-18 |
Foreign References:
JP2006306754A | 2006-11-09 | |||
JP2009519934A | 2009-05-21 | |||
JP2010533667A | 2010-10-28 | |||
JP2009504728A | 2009-02-05 | |||
JP2008540440A | 2008-11-20 | |||
JP2013518860A | 2013-05-23 | |||
JP2010539156A | 2010-12-16 |
Other References:
ANONYMOUS: "Processs for preparing dasatinib formulations", IP. COM JOURNAL IPCOM000227417D, 7 May 2013 (2013-05-07), pages 1, XP013157112, ISSN: 1533-0001
Attorney, Agent or Firm:
TAKAHASHI, HAYASHI AND PARTNER PATENT ATTORNEYS, INC. (JP)
Download PDF: